欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/3508/002
药品名称Spironolacton Accord 50 mg filmomhulde tabletten
活性成分
    • Spironolactone 50.0 mg
剂型Film-coated tablet
上市许可持有人Accord Healthcare B.V. Wintonlaan 200 3508 AD Utrecht Netherlands
参考成员国 - 产品名称Netherlands (NL)
Spironolacton Accord 50 mg, filmomhulde tabletten
互认成员国 - 产品名称
    • Germany (DE)
      Spironolacton Accord 50 mg Filmtabletten
    • Denmark (DK)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Sweden (SE)
    • Latvia (LV)
      Spironolactone Accord 50 mg apvalkotās tabletes
    • Lithuania (LT)
      Spironolactone Accord 50 mg plėvele dengtos tabletės
    • Estonia (EE)
      SPIRONOLACTONE ACCORD
    • Bulgaria (BG)
      Spironolacton Accord
许可日期2015/12/02
最近更新日期2025/06/30
药物ATC编码
    • C03DA01 spironolactone
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase